N39

O1-tert-butyl O2-ethyl O5-methyl (E,5R)-5-(1-methylindol-2-yl)-5-[(4-methylphenyl)sulfonylamino]pent-2-ene-1,2,5-tricarboxylate

Created:	2022-08-11
Last modified:	2023-09-23

Find Related PDB Entry
1 entries where N39 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	78
Chiral Atom Count	2
Bond Count	81
Aromatic Bond Count	16

2D diagram of N39

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	O1-tert-butyl O2-ethyl O5-methyl (E,5R)-5-(1-methylindol-2-yl)-5-[(4-methylphenyl)sulfonylamino]pent-2-ene-1,2,5-tricarboxylate
Systematic Name (OpenEye OEToolkits)	~{O}2-~{tert}-butyl ~{O}3-ethyl ~{O}6-methyl (2~{S},6~{R})-6-(1-methylindol-2-yl)-1-(4-methylphenyl)sulfonyl-2,5-dihydropyridine-2,3,6-tricarboxylate
Formula	C₃₁ H₃₆ N₂ O₈ S
Molecular Weight	596.691
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CCOC(=O)C1=CC[C](N([CH]1C(=O)OC(C)(C)C)[S](=O)(=O)c2ccc(C)cc2)(C(=O)OC)c3cc4ccccc4n3C
SMILES	OpenEye OEToolkits	2.0.7	CCOC(=O)C1=CCC(N(C1C(=O)OC(C)(C)C)S(=O)(=O)c2ccc(cc2)C)(c3cc4ccccc4n3C)C(=O)OC
Canonical SMILES	CACTVS	3.385	CCOC(=O)C1=CC[C@](N([C@@H]1C(=O)OC(C)(C)C)[S](=O)(=O)c2ccc(C)cc2)(C(=O)OC)c3cc4ccccc4n3C
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCOC(=O)C1=CC[C@@](N([C@@H]1C(=O)OC(C)(C)C)S(=O)(=O)c2ccc(cc2)C)(c3cc4ccccc4n3C)C(=O)OC
InChI	InChI	1.06	InChI=1S/C31H36N2O8S/c1-8-40-27(34)23-17-18-31(29(36)39-7,25-19-21-11-9-10-12-24(21)32(25)6)33(26(23)28(35)41-30(3,4)5)42(37,38)22-15-13-20(2)14-16-22/h9-17,19,26H,8,18H2,1-7H3/t26-,31+/m0/s1
InChIKey	InChI	1.06	FUSYRUNCXNWFDD-SUYBVONHSA-N

Related Resource References

Resource Name	Reference
PubChem	164885965

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.